Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
gptkb:A16AB04
|
| gptkbp:brand |
gptkb:Fabrazyme
|
| gptkbp:CASNumber |
339376-08-1
|
| gptkbp:developer |
gptkb:Genzyme
|
| https://www.w3.org/2000/01/rdf-schema#label |
agalsidase beta
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
enzyme replacement therapy
|
| gptkbp:molecularWeight |
101 kDa
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:product |
recombinant human alpha-galactosidase A
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea headache chills infusion reaction |
| gptkbp:status |
FDA approved
EMA approved |
| gptkbp:target |
alpha-galactosidase A deficiency
|
| gptkbp:UNII |
GZP2782OP0
|
| gptkbp:usedFor |
gptkb:Fabry_disease
|
| gptkbp:bfsParent |
gptkb:Fabrazyme
|
| gptkbp:bfsLayer |
7
|